- call +1-201-465-4211
- email sales@mrinsights.biz
Description
Scope of the Report:
The global NK Cell Therapy market is valued at 222.5 million USD in 2018 and is expected to reach 395.4 million USD by the end of 2024, growing at a CAGR of 15.5% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of NK Cell Therapy.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the NK Cell Therapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the NK Cell Therapy market by product type and applications/end industries.
Market Segment by Companies, this report covers
Nektar Therapeutics
Kiadis Pharma
Chipscreen Biosciences
Innate Pharma SA
Dragonfly Therapeutics
Affimed
Nkarta Therapeutics
Glycostem Therapeutics
Fate Therapeutics
NantWorks
Fortress Biotech
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
NK Cell Therapies
NK Cell Directed Antibodies
NK Cell agents took the largest market share segment, accounting for 82% and growing fastest
Market Segment by Applications, can be divided into
Cancer
Gastrointestinal Diseases
Others
Cancer was the most widely used area at 66%
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 NK Cell Therapy Market Overview
1.1 Product Overview and Scope of NK Cell Therapy
1.2 Classification of NK Cell Therapy by Types
1.2.1 Global NK Cell Therapy Revenue Comparison by Types (2019-2024)
1.2.2 Global NK Cell Therapy Revenue Market Share by Types in 2018
1.2.3 NK Cell Therapies
1.2.4 NK Cell Directed Antibodies
1.3 Global NK Cell Therapy Market by Application
1.3.1 Global NK Cell Therapy Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Cancer
1.3.3 Gastrointestinal Diseases
1.3.4 Others
1.4 Global NK Cell Therapy Market by Regions
1.4.1 Global NK Cell Therapy Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) NK Cell Therapy Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) NK Cell Therapy Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) NK Cell Therapy Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) NK Cell Therapy Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) NK Cell Therapy Status and Prospect (2014-2024)
1.5 Global Market Size of NK Cell Therapy (2014-2024)
2 Company Profiles
2.1 Nektar Therapeutics
2.1.1 Business Overview
2.1.2 NK Cell Therapy Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Nektar Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.2 Kiadis Pharma
2.2.1 Business Overview
2.2.2 NK Cell Therapy Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Kiadis Pharma NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.3 Chipscreen Biosciences
2.3.1 Business Overview
2.3.2 NK Cell Therapy Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Chipscreen Biosciences NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.4 Innate Pharma SA
2.4.1 Business Overview
2.4.2 NK Cell Therapy Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Innate Pharma SA NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.5 Dragonfly Therapeutics
2.5.1 Business Overview
2.5.2 NK Cell Therapy Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Dragonfly Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.6 Affimed
2.6.1 Business Overview
2.6.2 NK Cell Therapy Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Affimed NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.7 Nkarta Therapeutics
2.7.1 Business Overview
2.7.2 NK Cell Therapy Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Nkarta Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.8 Glycostem Therapeutics
2.8.1 Business Overview
2.8.2 NK Cell Therapy Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Glycostem Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.9 Fate Therapeutics
2.9.1 Business Overview
2.9.2 NK Cell Therapy Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Fate Therapeutics NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.10 NantWorks
2.10.1 Business Overview
2.10.2 NK Cell Therapy Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 NantWorks NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.11 Fortress Biotech
2.11.1 Business Overview
2.11.2 NK Cell Therapy Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Fortress Biotech NK Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
3 Global NK Cell Therapy Market Competition, by Players
3.1 Global NK Cell Therapy Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 NK Cell Therapy Players Market Share
3.2.2 Top 10 NK Cell Therapy Players Market Share
3.3 Market Competition Trend
4 Global NK Cell Therapy Market Size by Regions
4.1 Global NK Cell Therapy Revenue and Market Share by Regions
4.2 North America NK Cell Therapy Revenue and Growth Rate (2014-2019)
4.3 Europe NK Cell Therapy Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific NK Cell Therapy Revenue and Growth Rate (2014-2019)
4.5 South America NK Cell Therapy Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa NK Cell Therapy Revenue and Growth Rate (2014-2019)
5 North America NK Cell Therapy Revenue by Countries
5.1 North America NK Cell Therapy Revenue by Countries (2014-2019)
5.2 USA NK Cell Therapy Revenue and Growth Rate (2014-2019)
5.3 Canada NK Cell Therapy Revenue and Growth Rate (2014-2019)
5.4 Mexico NK Cell Therapy Revenue and Growth Rate (2014-2019)
6 Europe NK Cell Therapy Revenue by Countries
6.1 Europe NK Cell Therapy Revenue by Countries (2014-2019)
6.2 Germany NK Cell Therapy Revenue and Growth Rate (2014-2019)
6.3 UK NK Cell Therapy Revenue and Growth Rate (2014-2019)
6.4 France NK Cell Therapy Revenue and Growth Rate (2014-2019)
6.5 Russia NK Cell Therapy Revenue and Growth Rate (2014-2019)
6.6 Italy NK Cell Therapy Revenue and Growth Rate (2014-2019)
7 Asia-Pacific NK Cell Therapy Revenue by Countries
7.1 Asia-Pacific NK Cell Therapy Revenue by Countries (2014-2019)
7.2 China NK Cell Therapy Revenue and Growth Rate (2014-2019)
7.3 Japan NK Cell Therapy Revenue and Growth Rate (2014-2019)
7.4 Korea NK Cell Therapy Revenue and Growth Rate (2014-2019)
7.5 India NK Cell Therapy Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia NK Cell Therapy Revenue and Growth Rate (2014-2019)
8 South America NK Cell Therapy Revenue by Countries
8.1 South America NK Cell Therapy Revenue by Countries (2014-2019)
8.2 Brazil NK Cell Therapy Revenue and Growth Rate (2014-2019)
8.3 Argentina NK Cell Therapy Revenue and Growth Rate (2014-2019)
8.4 Colombia NK Cell Therapy Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue NK Cell Therapy by Countries
9.1 Middle East and Africa NK Cell Therapy Revenue by Countries (2014-2019)
9.2 Saudi Arabia NK Cell Therapy Revenue and Growth Rate (2014-2019)
9.3 UAE NK Cell Therapy Revenue and Growth Rate (2014-2019)
9.4 Egypt NK Cell Therapy Revenue and Growth Rate (2014-2019)
9.5 Nigeria NK Cell Therapy Revenue and Growth Rate (2014-2019)
9.6 South Africa NK Cell Therapy Revenue and Growth Rate (2014-2019)
10 Global NK Cell Therapy Market Segment by Type
10.1 Global NK Cell Therapy Revenue and Market Share by Type (2014-2019)
10.2 Global NK Cell Therapy Market Forecast by Type (2019-2024)
10.3 NK Cell Therapies Revenue Growth Rate (2014-2024)
10.4 NK Cell Directed Antibodies Revenue Growth Rate (2014-2024)
11 Global NK Cell Therapy Market Segment by Application
11.1 Global NK Cell Therapy Revenue Market Share by Application (2014-2019)
11.2 NK Cell Therapy Market Forecast by Application (2019-2024)
11.3 Cancer Revenue Growth (2014-2019)
11.4 Gastrointestinal Diseases Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global NK Cell Therapy Market Size Forecast (2019-2024)
12.1 Global NK Cell Therapy Market Size Forecast (2019-2024)
12.2 Global NK Cell Therapy Market Forecast by Regions (2019-2024)
12.3 North America NK Cell Therapy Revenue Market Forecast (2019-2024)
12.4 Europe NK Cell Therapy Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific NK Cell Therapy Revenue Market Forecast (2019-2024)
12.6 South America NK Cell Therapy Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa NK Cell Therapy Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure NK Cell Therapy Picture
Table Product Specifications of NK Cell Therapy
Table Global NK Cell Therapy and Revenue (Million USD) Market Split by Product Type
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
